MORAb-003

farletuzumab · Morphotek

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MORAb-003, covering 2012-02-15 to 2021-12-08. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Extension Study of the Efficacy of MORAb-003 [Phase 2]